Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Based Gene Editing Therapeutic Market Forecast Highlights Expansion From $6.92 Billion To $15.85 Billion Through 2030
CRISPR-Based Gene Editing Therapeutic market size reached $6.93 billion in 2026 and is expected to grow to $15.85 billion by 2030 at a 23.0% CAGR. Major players: Novartis, AstraZeneca, Beam Therapeutics.

